• L. Kovalevska R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology
  • T. Zadvornyj R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology
  • N. Lukianova R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology
  • E. Kashuba R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology




AIP, bioinformatic analysis, expression pattern, PKN1, prostate cancer, UCKL1


Background: The evolution of research on the therapy of prostate cancer (PC) depends on a study of molecules that are involved in the progression of this disease. Nevertheless, there is a need for additional biomarkers that would help to refine the molecular profile of PC and propose the personalized therapeutic approach. Aim: To study differential expression patterns of the AIP, UCKL1, and PKN1 genes in blood sera and tumor tissue of patients with PC with different Gleason scores. Materials and Methods: The total extracellular RNA was isolated from blood sera of 44 PC patients and 4 healthy donors. cDNAs were synthesized and quantitative polymerase chain reaction (qPCR) was performed. Immunohistochemical study of the UCKL, AIP and PKN1 proteins was performed on deparaffinized sections of tumors. The study was supplemented by a bioinformatic analysis of the publicly available databases. Results: The UCKL1, AIP, PKN1 genes were overexpressed at the mRNA level in blood sera of PC patients, compared to healthy donors. Extracellular mRNA levels of AIP and UCKL-1 were 100-1000-fold increased in all PC samples compared to the healthy donors but without significant inequality between the groups of PC cases differing by the Gleason score. The highest levels were detected in the samples from PC patients with the Gleason score > 9. The PKN1 expression was higher in PC patients compared with healthy donors but without significant difference between the groups. Conclusions: From the three chosen genes, AIP and UCKL1 showed similar pattern of expression assessed either by extracellular mRNA levels in patient sera or the protein in PC tissues. AIP was up to 1000-fold increased in all PC samples, compared to the healthy donors, with the highest levels in PC cases with Gleason score > 9. Expression levels of the AIP and UCKL1 genes in the PC patient sera may be used as an additional criterion for prognosis of tumor progression.


Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and biology of prostate cancer. Genes Dev 2018; 32: 1105–40. https://doi.org/10.1101/gad.315739.118

Fedorenko Z, Michailovich Yu, Goulak L, et al. Cancer in Ukraine 2019–2020: Incidence, mortality, prevalence and other relevant statistics. Bull Nat Cancer Reg Ukraine 2021; 22.

Humphrey PA. Histopathology of prostate cancer. Cold Spring Harb Perspect Med 2017; 7: a030411. https://doi.org/10.1101/cshperspect.a030411

Humphrey PA, Moch H, Cubilla AL, et al. The 2016 WHO classification of tumours of the urinary system and male genital organs — Part B: Prostate and bladder tumours. Eur Urol 2016; 70: 106–19. https://doi.org/10.1016/j.eururo.2016.02.028

Turnham DJ, Bullock N, Dass MS The PTEN conundrum: how to target PTEN-deficient prostate cancer. Cells 2020; 9: 2342. https://doi.org/10.3390/cells9112342

Fonseca-Alves CE, Kobayashi PE, Rivera Caldero´n LG, et al. Immunohistochemical panel to characterize canine prostate carcinomas according to aberrant p63 expression. PLoS One 2018; 13: e0199173. https://doi.org/10.1371/journal.pone.0199173

Papachristodoulou A, Rodriguez-Calero A, Panja S, et al. NKX3.1 localization to mitochondria suppresses prostate cancer initiation. Cancer Discov 2021; 11: 2316–33. https://doi.org/10.1158/2159-8290.CD-20-1765

Dariane C, Clairefond S, Péant B, et al. High keratin-7 expression in benign peritumoral prostatic glands is predictive of bone metastasis onset and prostate cancer-specific mortality. Cancers 2022; 14: 1623. https://doi.org/10.3390/cancers14071623

Ilka K, Carsten S, Klaus J, et al. Sensitivity of HOXB13 as a diagnostic immunohistochemical marker of prostatic origin in prostate cancer metastases: comparison to PSA, prostein, androgen receptor, ERG, NKX3.1, PSAP, and PSMA. Int J Mol Sci 2017; 18: 1151. https://doi.org/10.3390/ijms18061151

Zadvornyi TV, Lukianova NYu, Borikun TV, et al. NANOG as prognostic factor of prostate cancer course. Exp Oncol 2020; 42: 94–100. https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14673

Yan Y, Zuo X, Wei D. Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target. Stem Cells Transl Med 2015; 4: 1033–43. https://doi.org/10.5966/sctm.2015-0048

Li C, Liu S, Yan R, et al. CD54-NOTCH1 axis controls tumor initiation and cancer stem cell functions in human prostate cancer. Theranostics 2017; 7: 67–80. https://doi.org/10.7150/thno.16752

Kovalevska L, Kashuba E, Zadvornyj T. Differential expression patterns of AIP, UCKL1, and PKN1 genes in breast cancer of different molecular subtypes. Exp Oncol 2021; 43: 298–305. https://doi.org/10.32471/exp-oncology.2312-8852.vol-43-no-4.17067

Hernández-Ramírez LC, Morgan RML, Barry S, et al. Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland. Oncotarget 2018; 9: 9177–98. https://doi.org/10.18632/oncotarget.24183

Wang C, Cui A, Bukenya M, et al. Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade. Cell Rep 2021; 37: 110021. https://doi.org/10.1016/j.celrep.2021.110021

Przybyla T, Sakowicz-Burkiewicz M, Maciejewska I, et al. Suppression of ID1 expression in colon cancer cells increases sensitivity to 5-fluorouracil. Acta Biochim Pol 2017; 64: 315–22. https://doi.org/10.18388/abp.2016_1421

Buivydiene A, Liakina V, Valantinas J, et al. expression levels of the uridine-cytidine kinase like-1 protein as a novel prognostic factor for hepatitis C virus-associated hepatocellular carcinomas. Acta Naturae 2017; 9: 108–14.

Buivydiene A, Liakina V, Kashuba E, et al. Impact of the Uridine(-)Cytidine Kinase Like-1 Protein and IL28B rs12979860 and rs8099917 SNPs on the development of hepatocellular carcinoma in cirrhotic chronic hepatitis C patients-A pilot study. Medicina (Kaunas) 2018; 54: 67. https://doi.org/10.3390/medicina54050067

Kashuba E, Kashuba V, Sandalova T, et al. Epstein-Barr virus encoded nuclear protein EBNA-3 binds a novel human uridine kinase/uracil phosphoribosyltransferase. BMC Cell Biol 2002; 3: 23. https://doi.org/10.1186/1471-2121-3-23

Wang X, Ge Y, Shi M, et al. Protein kinase N1 promotes proliferation and invasion of liver cancer. Exp Ther Med 2021; 21: 651. https://doi.org/10.3892/etm.2021.10083

Jilg CA, Ketscher A, Metzger E, et al. PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells. Oncotarget 2014; 5: 12646–64. https://doi.org/10.18632/oncotarget.2653

Kovalevska LM, Zadvornyj TV, Malysheva TA, et al. Study on relative gene expression levels in tumor tissue and in blood serum of cancer patients. Oncologiya 2021, 23: 149–53 (in Ukrainian). https://doi.org/10.32471/oncology.2663-7928.t-23-3-2021-g.9761

Di Vizio D, Morello M, Dudley AC, et al. Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. Am J Pathol 2012; 181: 1573–84. https://doi.org/10.1016/j.ajpath.2012.07.030

Minciacchi VR, Freeman MR, Di Vizio D. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol 2015; 40: 41–51. https://doi.org/10.1016/j.semcdb.2015.02.010

Sadik N, Cruz L, Gurtner A, et al. Extracellular RNAs: a new awareness of old perspectives. Methods Mol Biol 2018; 1740: 1–15. https://doi.org/10.1007/978-1-4939-7652-2_1

Yuan T, Huang X, Woodcock M, et al. Plasma extracellular RNA profiles in healthy and cancer patients. Sci Rep 2016; 6: 19413. https://doi.org/10.1038/srep19413

Savelyeva AV, Kuligina EV, Bariakin DN, et al. Variety of RNAs in peripheral blood cells, plasma, and plasma fractions. Biomed Res Int 2017; 2017: 7404912. https://doi.org/10.1155/2017/7404912

Jung YW, Shim JI, Shim SH, et al. Global gene expression analysis of cell-free RNA in amniotic fluid from women destined to develop preeclampsia. Medicine (Baltimore) 2019; 98: e13971. https://doi.org/10.1097/MD.0000000000013971

Lawson P, Sholl AB, Brown JQ, et al. Persistent homology for the quantitative evaluation of architectural features in prostate cancer histology. Sci Rep 2019; 9: 1139. https://doi.org/10.1038/s41598-018-36798-y




How to Cite

Kovalevska, L., Zadvornyj, T., Lukianova, N., & Kashuba, E. (2023). DIFFERENTIAL EXPRESSION PATTERN OF AIP, UCKL1, AND PKN1 GENES IN PROSTATE CANCER PATIENTS. Experimental Oncology, 44(1), 47–51. https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-1.17380



Original contributions

Most read articles by the same author(s)

1 2 > >>